A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Antihistamines: Oral histamine-blocking medications help to reduce eczema-related symptoms caused by triggers like environmental allergies. Topical steroid creams and ointments: A healthcare provider ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Nektar Therapeutics stock launched Tuesday after the biotech company hit every goal in a midstage study of its eczema ...

Discover 7 surprising facts about spongiotic dermatitis that affect millions. Learn hidden symptoms, causes, and treatments ...

Nektar Therapeutics said on Tuesday its experimental eczema drug had met the main goal of a mid-stage study, sending its shares up by more than 140% in premarket trading.In the 393-patient trial, drug ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Nektar Therapeutics (NKTR) saw its stock surge 86% Tuesday morning after reporting strong midstage trial results for its ...

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with atopic dermatitis or eczema.

Breakthrough study could lead to new treatments as experts explore how skin fungi trigger debilitating skin condition ...

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...